The Serum Institute of India and Bharat Biotech are expected to continue advanced clinical trials of COVID-19 intranasal vaccines in the coming months, once they receive regulatory approval, the Minister of Health said today. , Dr Harsh Vardhan.
Mr Vardhan said the late-stage trial typically involved thousands of participants, sometimes 30,000 to 40,000.
Of the vaccines currently in phase 3 trials, all are given by injection, according to the World Health Organization (WHO).
On Saturday, Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) said they had received new approval to conduct advanced clinical trials in India of the Russian COVID-19 vaccine.
Coronavirus infections have increased by another 61,871 in the past 24 hours in the country, data released on Sunday showed, although the health ministry said it saw a steady downward trend in active cases.
The Indian Council for Medical Research (ICMR) said it would review its treatment protocol for COVID-19 after the WHO found that some of the commonly used drugs, including remdesivir, had little or no effect. impact on a patient’s chances of survival, according to reports.